Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension

Azilsartan–chlorthalidone fixed combination is a new drug in the management of hypertension. Azilsartan has been shown to have greater blood pressure-lowering effects than other angiotensin-receptor blockers (ARBs), and the debate regarding the superiority of chlorthalidone over hydrochlorothiazide...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuster, Jerrica E, Bleske, Barry E, Dorsch, Michael P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383350/
https://www.ncbi.nlm.nih.gov/pubmed/22745562
http://dx.doi.org/10.2147/VHRM.S22583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383350/
https://www.ncbi.nlm.nih.gov/pubmed/22745562
http://dx.doi.org/10.2147/VHRM.S22583

Ejemplares similares